Gallium citrate

枸橼酸镓

Report date: 2022/07/04 19:38:02
QIDP

Base Information

Drug NameGallium citrate
Drug Alias Namegallium(III) citratePanaecinAR-501Ga-Cit
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIonising radiation emittersMultienzyme complexes inhibitorsDNA synthesis inhibitors
TargetsMultienzyme complexes
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAridis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAridis Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A